We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
19 Apr 2021 - 22 Apr 2021
Virtual Venue
20 Apr 2021 - 22 Apr 2021
Virtual Venue

Wearable Biosensor Facilitates Remote Monitoring

By HospiMedica International staff writers
Posted on 12 Jan 2021
Print article
Image: A button-sized sensor seamlessly captures multi-parameter vital signs and biometrics (Photo courtesy of BioIntelliSense)
Image: A button-sized sensor seamlessly captures multi-parameter vital signs and biometrics (Photo courtesy of BioIntelliSense)
A coin-sized disposable medical wearable device continuously monitors temperature, heart rate, and respiratory rate at rest.

The BioIntelliSense (Denver, CO, USA) BioButton is a medical-grade Data-as-a-Service (DaaS) platform that seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The BioButton pairs to the BioMobile app for daily screening surveys, which enable the combined remote patient monitoring (RPM) solution to identify statistically meaningful trends for early screening of potential COVID-19 infection, based on guidelines established by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA)

“The commercial launch of the BioButton COVID-19 symptom screening and vaccine monitoring solution is timely in addressing the growing challenge of safe return to worksites, school, travel, conferences and entertainment,” said James Mault, MD, CEO of BioIntelliSense. “The BioButton is the newest addition to our biosensor portfolio and data services model for public health and clinical applications that span infectious disease, orthopedics, oncology, and cardiac care.”

Even without the current need for monitoring potential COVID-19 infection, increasing healthcare costs, an aging population, and improved patient outcomes with advanced RPM technologies are motivating the shift of eligible patients toward home care programs. Remote and continuous monitoring have shown a reduction in readmissions, improved patient outcomes, and overall decrease in cost of care compared to a traditional hospital stay.

Related Links:
BioIntelliSense
U.S. Centers for Disease Control and Prevention



Print article

Channels

Business

view channel
Image: Respicardia’s remedē System (Photo courtesy of Respicardia, Inc.)

Zoll Medical Acquires CSA Systems Manufacturer Respicardia

ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has acquired Respicardia, Inc. (Minnetonka, MN, USA), a provider of novel implantable neurostimulators for the treatment of moderate... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.